Priority Date: 15.07.08 (EP 20080290694)

Oxazolopyrimidines as Edg-1 receptor agonists

  • Application ID: EP13151034
  • Status: APPLICATION WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Sanofi-Aventis Deutschland GmbH is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.07.2008 - Priority Date (EP 20080290694)
  • 24.04.2013 - Publication A1 (EP2583720)